Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab

CD20 is a B-lymphocyte specific integral membrane protein, an activated-glycosylated phosphoprotein expressed on the surface of B-cells and a clinically validated target of monoclonal antibodies such as rituximab, ocrelizumab, ofatumumab and obinutuzumab in the treatment of all B cell lymphomas and...

Descripción completa

Detalles Bibliográficos
Autores principales: Agez, Morgane, Mandon, Elodie Desuzinges, Iwema, Thomas, Gianotti, Reto, Limani, Florian, Herter, Sylvia, Mössner, Ekkehard, Kusznir, Eric A., Huber, Sylwia, Lauer, Matthias, Ringler, Philippe, Ferrara, Claudia, Klein, Christian, Jawhari, Anass
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757138/
https://www.ncbi.nlm.nih.gov/pubmed/31548565
http://dx.doi.org/10.1038/s41598-019-50031-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757138/
https://www.ncbi.nlm.nih.gov/pubmed/31548565
http://dx.doi.org/10.1038/s41598-019-50031-4

Ejemplares similares